Millions of people worldwide suffer from devastating autoimmune disease and cancer resulting from disregulation of their immune systems. Scientists at Lycera have identified fundamental approaches to immune modulation, with important potential applications in the treatment of diverse diseases. Our integrated research teams including experienced medicinal chemists, immunologists, and physicians, are transforming proprietary research findings in immune biology into novel compounds advancing in clinical and preclinical studies. Our aim is to develop the next generation of drugs able to bring original solutions to patients with the greatest need.